Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction

Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction

The Epstein-Barr virus (EBV) infects more than 95% of adults worldwide and is associated with various malignant tumors and immune diseases, imparting a huge disease burden on the human population. Available EBV vaccines are imminent. Prophylactic vaccines can effectively prevent the spread of infect...

Full description

Bibliographic Details
Main Authors: Jing Cai, Bodou Zhang, Yuqi Li, Wanfang Zhu, Toshihiro Akihisa, Wei Li, Takashi Kikuchi, Wenyuan Liu, Feng Feng, Jie Zhang
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Vaccines
Subjects:
Epstein-Barr virus
vaccine
T cells
antibodies
oncogenic
Online Access:https://www.mdpi.com/2076-393X/9/11/1290

Similar Items

Similar Items